Article PDF
References
Bracken M B, Shepard M J, Collins W F et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med 1990;322: 1405–1411.
Senter H J, Venes J L . Altered blood flow and secondary injury in experimental spinal cord trauma. J Neurosurg 1978;49: 569–578.
Means E D, Anderson D K, Waters T R, Kalaf L . Effects of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 1981;55: 200–208.
Young W, Flamm E S . Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J Neurosurg 1982;57: 667–673.
Anderson D K, Means E D, Waters T R, Green E S . Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg 1982;56: 106–113.
Braughler J M, Hall E D . Correlation of methylprednisolone levels in cat spinal cord with its effects on (Na2+ k+)-ATPase, lipid peroxidation, and alpha motor neuron function. J Neurosurg 1982;56: 838–844.
Hall E D, Braughler J M . Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982; 18: 320–327.
Hall E D, Wolf D L, Braughler J M . Effects of a single large dose of methylprednisolone sodium succinate on posttraumatic spinal cord ischemia: Dose-response and time-action analysis. J Neurosurg 1984;61: 124–130.
Braughler J M, Hall E D, Means E D, Waters T R, Anderson D K . Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987;67: 102–105.
Molinari G F . Why model strokes? Stroke 1988;19: 1195–1197.
Wiebers D O, Adams H P, Jr, Whisnant JP. Animal models of stroke: Are they relevant to human disease? Stroke 1990;21: 13.
Balentine J D . Pathology of experimental spinal cord trauma. I. The necrotic lesions as a function of vascular injury. Lab Invest 1978;39: 236–253.
Balentine J D . Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest 1978;39: 254–266.
Balentine J D . Hypotheses in spinal cord trauma research. In: Becker DP, Povlishock JT, eds Central Nervous System Trauma Status Report. Bethesda: National Institutes of Health, 1985:pp 455–461.
Young W . Blood flow, metabolic and neurophysiological mechanisms in spinal cord injury. In: Becker DP, Povlishock JT, eds Central Nervous System Trauma Status Report. Bethesda: National Institutes of Health, 1985:pp 463–473.
Young W . Secondary CNS injury. J Neurotrauma 1988;5: 219–221.
Anderson D K, Saunders R D, Demediuk P, et a l . Lipid hydrolysis and peroxidation in injured spinal cord: Partial protection with methylprednisolone or vitamin E and selenium. Cent Nerv System Trauma 1985;2: 257–267.
Braughler J M, Pregenzer J F, Chase R L, Duncan L A, Jacobsen E J, McCall J M . Novel 21-amino substituted steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987;262: 10438–10440.
Anderson D K, Braughler J M, Hall E D, Waters T R, McCall J M, Means E D . Effects of treatment with U74006F on neurological recovery following experimental spinal cord injury. J Neurosurg 1988;69: 562–567.
Hsu C Y, Dimitrijevik M R . Commentary: Methylprednisolone in spinal cord injury: The possible mechanism of action. J Neurotrauma 1990;7: 118–119.
Troiano R A, Hafstein M P, Zito G, Ruderman M I, Dowling P C, Gok S D . The effect of oral corticosteroid dosage on CT enhancing multiple sçlerosis plaques. J Neurol Sci 1985;70: 67–72.
Gallin J I, Goldstein I M, Snyderman, R Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1988.
Lewis G P . Mediators of Inflammation. Wright: Bristol, 1986.
Hsu C Y, Liu T H, Hogan E L . Lipid inflammatory mediators in ischemic brain edema and injury. In: Bazan NG, ed. New Trends in Lipid Mediators. Basel: Karger, Vol. 4,1990;pp 85–112.
Becker J, Grasso R J . Suppression of phagocytosis by dexamethasone in macrophage cultures: Inability of arachidonic acid, indomethacin, and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factor. Int J Immunopharmacol 1985;7: 839–847.
Matteo M R, Smith R S . Neurophil-dependent tissue damage. Agents Actions 1988;25: 61–62.
Williams K I, Higgs G A . Eiconsanoids and inflammation. J Pathol 1988;156: 101–110.
Espersen G T, Ernst E, Vestergaard M, Pedersen J A, Grunnet N . Changes in PMN leukocyte migration activity and complement C3d levels in RA patients with high disease activity during steroid treatment. Scand J Rheumatol 1989;8: 51–56.
Schleimer R P, Freeland H S, Peters S P, Brown K E, Derse C P . An assessment of the effects of glucocortieoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 1989;250: 598–605.
DiRosa M, Persico P . Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leukocytes. Br J Pharmacol 1979;66: 161–163.
Kontos H A, Wei E P, Ellis E F et al. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ Res 1985;57: 142–151.
Hirata F, Schiffman E, Venkasubramanian V, Salomon D . A phospholipase A 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 1980;77: 2533–2536.
Blackwell G J, Carnuccio R, DiRosa M, Flower R J, Parente L, Persico P . Macrocortin : A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (Lond) 1980;287: 147–149.
Goodman J G, Bingham W G, Hunt W E . Platelet aggregation in experimental spinal cord injury. Arch Neurol 1979;30: 197–201.
Means E D, Anderson D K . Neuronophagia by leukocytes in experimental spinal cord injury. J Neuropathol Exp Neurol 1983;42: 707–719.
Xu J, Hsu C Y, Liu T H, Hogan E L, Perot P L, Tai H H . Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem 1990;55: 907–912.
Griffiths I R, Miller R . Vascular permeability to protein and vasogenic oedema in experimental concussive injuries to the canine spinal cord. J Neurol Sci 1974;22: 291–304.
Stewart W B, Wagner F C . Vascular permeability changes in the contused feline spinal cord. Brain Res 1979;169: 163–167.
Hsu C Y, Hogan E L, Gadsen R H Sr, Spicer KM, Shi MP, Cox RK. Vascular permeability in experimental spinal cord injury. J Neurol Sci 1985;70: 275–282.
Banik N L, Hogan E L, Power J M, Whetstine L J . Degradation of neurofilament proteins in spinal cord injury. Neurochem Res 1982;7: 1465–1475.
Braughler J M, Hall E D . Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degration and energy metabolism. J Neurosurg 1984;61: 290–295.
Demediuk P, Saunders R D, Anderson D K, Means E D, Horrocks L A . Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc Natl Acad Sci USA 1985;82: 7071–7075.
Hsu C Y, Halushka P V, Hogan E L, Banik N L, Lee W A, Perot P L, Jr. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology 1985;35: 1003–1009.
Chao J, Xu J, Hsu C Y . Kaininogen and kinins in experimental spinal cord injury. FASEB J 1988;2 Al: 145.
Kontos H A, Wei E P, Povlishock J T, Chrisman C W . Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 1984;55: 295–303.
Ellis E F, Chao J, Heizer M L . Brain kininogen following experimental brain injury: Evidence for a secondary event. J Neurosurg 1989;71: 437–442.
Giulian D, Robertson C . Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990;27: 33–42.
Young W, Yen V, Blight A . Extracellular calcium ionic activity in experimental spinal cord contusion. Brain Res 1982;253: 105–113.
Happel R D, Smith K P, Banik N L, Powers J, Hogan E L . Ca 2-accumulation in experimental spinal cord trauma. Brain Res 1981;211: 476–479.
Balentine J D, Spector M . Calcification of axons in experimental spinal cord trauma. Ann Neurol 1977;2: 520–523.
Hall E D, Wolf D L . A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg 1986;64: 951–961.
Choi D W . Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neuroscience Lett 1985;58: 293–297.
Faden A I, Simon R P . A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 1988;23: 623–626.
Faden A I, Lemke M, Simon R P, Noble L J . N-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomic, and neurochemical studies. J Neurotrauma 1988;5: 33–45.
Patel J, Zinkland W C, Thompson C, Keith R, Solama A . Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytoxicity. J Neurochem 1990;54: 849–854.
Faden A I, Jacobs T P, Holaday J W . Comparison of early and late naloxone treatment in experimental spinal injury. Neurology 1982;32: 677–681.
Flamm E S, Young W, Collins W F, Piepmeier J, Clifton G L, Fischer B . A phase I trial of naloxone treatment in acute spinal cord injury. J Neurosurg 1985;63: 390–397.
Yaksh T L . Opioid receptor systems and the endorphins: a review of their spinal organization. J Neurosurg 1987;67: 157–176.
Faden A I . Opioid and non opioid mechanisms may contribute to cynorphin's pathophysiological actions in spinal cord injury. Ann Neurol 1990;27: 67–74.
Cheng M K, Robertson C, Grossman R G, Foltz R, Williams V . Neurological outcome correlated with spinal evoked potentials in a spinal cord ischemia model. J Neurosurg 1984;60: 786–7795.
Shi R Y, Lucas J H, Wolf A, Gross G W . Calcium antagonists fail to protect mammalian spinal neurons after physical injury. J Neurotrauma 1989;6: 261–276.
Fehlings M G, Tator C H, Linden R D . The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989;71: 403–416.
Hsu C Y . Commentary. J Neurotrauma 1989;6: 277–278.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simpson, R., Hsu, C. & Dimitrijevic, M. The experimental basis for early pharmacological intervention in spinal cord injury. Spinal Cord 29, 364–372 (1991). https://doi.org/10.1038/sc.1991.52
Issue Date:
DOI: https://doi.org/10.1038/sc.1991.52